Patent · US Active

Treatment of epithelial cysts by intracystic injection of antineoplastic particles

US11523983B2 · kind B2 · utility

0Cited by

55References

18Claims

0Family size

Assignee

CRITITECH, INC. · US

Inventors

Gere S. diZerega · Fort Worth, US
Michael Baltezor · Lee's Summit, US
Charles Decedue · Lawrence, US
Sam Campbell · Lawrence, US
Matthew McClorey · Lawrence, US
Marc Iacobucci · Lawrence, US
Holly Maulhardt · Lawrence, US

Key dates

Filing date	May 10, 2021
Grant date	Dec 13, 2022
Priority date	—
Expiry date	Jun 10, 2041

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed herein are methods for treating epithelial cysts, including pancreatic cysts, in a subject by intracystic injection of compositions comprising antineoplastic particles, including taxane particles such as paclitaxel particles and docetaxel particles.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.